Literature DB >> 16076506

Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth.

Jason M Correnti1, Paul J Brindley, Edward J Pearce.   

Abstract

Schistosoma mansoni is an important flatworm parasite of man that has remained intractable to experimental analyses of gene function. We have developed an approach for using dsRNA to target schistosome transcripts for RNA interference, and used it to address the role of cathepsin B (SmCB1), a cysteine protease that has been proposed to play a central role in hemoglobin digestion in the schistosome gut. Electroporation of 3 h old larval schistosomes with SmCB1-specific dsRNA (SmCB1-dsRNA) resulted in a greater than 10-fold reduction in SmCB1 transcript levels that persisted for >20 days. RNAi mediated reductions in transcript levels led to associated reductions in SmCB1 enzyme activity. Schistosomes treated with SmCB1-dsRNA were viable and developed intestinal heme pigmentation indicative of hemoglobin digestion, but showed significant growth retardation when compared to control parasites, indicating that SmCB1 function is not essential for hemoglobin digestion but is necessary for normal parasite growth. This effect on growth was apparent when parasites were maintained in culture or introduced into mammalian hosts. The report sheds new light on the role of SmCB1 and provides a template for using RNAi to examine gene function in the mammal-parasitic stages of schistosomes during early development in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076506     DOI: 10.1016/j.molbiopara.2005.06.007

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  77 in total

1.  Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni.

Authors:  Elissaveta B Tchoubrieva; Poh C Ong; Robert N Pike; Paul J Brindley; Bernd H Kalinna
Journal:  Cell Mol Life Sci       Date:  2010-03-26       Impact factor: 9.261

2.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  Profiling Schistosoma mansoni development using serial analysis of gene expression (SAGE).

Authors:  David L Williams; Ahmed A Sayed; Jeremiah Bernier; Shanda R Birkeland; Michael J Cipriano; Alexandria R Papa; Andrew G McArthur; Andrew Taft; Jon J Vermeire; Timothy P Yoshino
Journal:  Exp Parasitol       Date:  2007-05-13       Impact factor: 2.011

4.  Schistosome asparaginyl endopeptidase (legumain) is not essential for cathepsin B1 activation in vivo.

Authors:  Greice Krautz-Peterson; Patrick J Skelly
Journal:  Mol Biochem Parasitol       Date:  2008-01-04       Impact factor: 1.759

Review 5.  RNA interference in infectious tropical diseases.

Authors:  Seokyoung Kang; Young S Hong
Journal:  Korean J Parasitol       Date:  2008-03       Impact factor: 1.341

6.  An improved and secreted luciferase reporter for schistosomes.

Authors:  Guofeng Cheng; Richard E Davis
Journal:  Mol Biochem Parasitol       Date:  2007-07-01       Impact factor: 1.759

7.  Protocols for gene silencing in schistosomes.

Authors:  David Ndegwa; Greice Krautz-Peterson; Patrick J Skelly
Journal:  Exp Parasitol       Date:  2007-08-15       Impact factor: 2.011

Review 8.  Helminth infections: the great neglected tropical diseases.

Authors:  Peter J Hotez; Paul J Brindley; Jeffrey M Bethony; Charles H King; Edward J Pearce; Julie Jacobson
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 9.  In vitro manipulation of gene expression in larval Schistosoma: a model for postgenomic approaches in Trematoda.

Authors:  Timothy P Yoshino; Nathalie Dinguirard; Marina de Moraes Mourão
Journal:  Parasitology       Date:  2009-12-07       Impact factor: 3.234

Review 10.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.